We sought to evaluate the efficacy of abciximab as adjunctive therapy to routine infarct-related artery (IRA) stenting.

A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction / D. Antoniucci, A. Rodriguez, A. Hempel, R. Valenti, A. Migliorini, F. Vigo, G. Parodi, C. Fernandez-Pereira, G. Moschi, A. Bartorelli, G. M. Santoro, L. Bolognese, A. Colombo. - In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. - ISSN 0735-1097. - 42:11(2003 Dec 03), pp. 1879-85-1885.

A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction

A. Bartorelli;
2003

Abstract

We sought to evaluate the efficacy of abciximab as adjunctive therapy to routine infarct-related artery (IRA) stenting.
Immunoglobulin Fab Fragments; Anticoagulants; Technetium Tc 99m Sestamibi; Humans; Aged; Coronary Restenosis; Antibodies, Monoclonal; Adult; Stents; Middle Aged; Myocardial Infarction; Chemotherapy, Adjuvant; Female; Male
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
3-dic-2003
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/186594
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 252
  • ???jsp.display-item.citation.isi??? 189
social impact